OTCMKTS:BABYF Else Nutrn (BABYF) Stock Price, News & Analysis $0.03 0.00 (0.00%) As of 07/8/2026 Add Compare Share Share Stock Analysis Stock AnalysisChartEarningsHeadlinesSEC FilingsBuy This Stock About Else Nutrn Stock (OTCMKTS:BABYF) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Else Nutrn alerts:Sign Up Key Stats Today's Range$0.03▼$0.0450-Day Range$0.01▼$0.0452-Week Range$0.01▼$0.80Volume46,020 shsAverage Volume137,086 shsMarket Capitalization$1.44 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview Else Nutrition Holdings Inc is a plant-based infant and toddler nutrition company that develops dairy-free, soy-free and gluten-free formula powders under its flagship ELSE brand. The company’s core product line includes Stage 1 infant formula and Stage 3 toddler nutrition powders formulated with a proprietary blend of almond, buckwheat and tapioca ingredients designed to mimic the nutritional profile of traditional milk‐based formulas. These products are non-GMO and aim to address food sensitivities and allergen concerns in early childhood nutrition. Founded in 2019 and headquartered in Tel Aviv, Israel, Else Nutrition began commercial sales in 2021 with initial distribution in Canada and Israel. Its manufacturing takes place in European Union-certified facilities, and products are sold through e-commerce channels as well as selected retail partners. Beyond Canada and Israel, Else Nutrition has entered into distribution partnerships in parts of Europe and is working toward regulatory approvals to support an expansion into the U.S. market. Led by CEO Hadar Barshewitz-Attias and a management team with backgrounds in nutrition science and consumer packaged goods, Else Nutrition places a strong emphasis on research and development. The company is investing in clinical studies and regulatory compliance to support the safety and efficacy of its existing products, while also exploring the development of additional age-stage formulas and new delivery formats within the plant-based pediatric nutrition category.AI Generated. May Contain Errors. Read More Receive BABYF Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Else Nutrn and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. BABYF Stock News HeadlinesCanadian Securities Exchange Welcomes Listing of Else Nutrition Holdings Inc.July 8, 2026 | finance.yahoo.comElse Nutrition Confirms Trading on a Post-Consolidation BasisJuly 8, 2026 | prnewswire.comA letter from Shannon StansberryPorter Stansberry nearly canceled the entire project. When he first saw the claimed returns - only one down year in nearly two decades and total gains of almost 2,000% - his immediate reaction was disbelief. It took a trusted friend's personal vouching for Emmet Savage and a face-to-face trip to Ireland to change his mind. The full documentary, Investigating Project Prophet, is now live.July 22 at 1:00 AM | Porter & Company (Ad)Else Nutrition Announces CSE Listing and ConsolidationJuly 7, 2026 | prnewswire.comElse Nutrition Announces CSE Conditional ApprovalJune 29, 2026 | prnewswire.comElse Nutrition Holdings Inc BABYFJune 26, 2026 | morningstar.comMElse Nutrition Holdings Inc BABYJune 5, 2026 | morningstar.comMElse Nutrition kicks off a Manufacturing Drive in Q2 2026June 1, 2026 | finance.yahoo.comSee More Headlines BABYF Stock Analysis - Frequently Asked Questions How have BABYF shares performed this year? Else Nutrn's stock was trading at $0.0777 at the start of the year. Since then, BABYF stock has decreased by 67.8% and is now trading at $0.0250. How were Else Nutrn's earnings last quarter? Else Nutrn Hldg (OTCMKTS:BABYF) posted its quarterly earnings data on Friday, May, 15th. The company reported ($0.03) earnings per share for the quarter. How do I buy shares of Else Nutrn? Shares of BABYF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Company Calendar Last Earnings5/15/2026Today7/22/2026Fiscal Year End12/31/2026Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry MED PRODUCTS Sub-IndustryN/A Current SymbolOTCMKTS:BABYF CIK1807936 Webwww.elsenutrition.com Phone888-879-3573FaxN/AEmployees32Year Founded2018Profitability EPS (Trailing Twelve Months)($0.63) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$6.36 million Net Margins-119.19% Pretax Margin-89.40% Return on EquityN/A Return on Assets-207.05% Debt Debt-to-Equity RatioN/A Current Ratio0.39 Quick Ratio0.19 Sales & Book Value Annual Sales$4.32 million Price / Sales0.33 Cash FlowN/A Price / Cash FlowN/A Book Value($0.08) per share Price / Book-0.31Miscellaneous Outstanding Shares57,490,000Free FloatN/AMarket Cap$1.44 million OptionableNot Optionable Beta0.73 Social Links Don't Wait for the OpenAI IPOThe AI wave will soon hit public markets with Anthropic and OpenAI set to go public later this year. However, you don't have to wait to invest. This report shows seven AI stocks that you can buy today while the big model providers get ready to go public.Get This Free Report This page (OTCMKTS:BABYF) was last updated on 7/22/2026 by MarketBeat.com Staff. From Our PartnersAmerica’s answer to universal basic incomeRobert Kiyosaki, author of Rich Dad Poor Dad, is highlighting an income strategy he calls the Patriot Income P...Freedom Financial | SponsoredSmall Colorado Company (Backed by Sam Altman) Could Save U.S. Power GridA small Colorado company has secured rights to technology that could prevent the U.S. public power grid from c...Altimetry | SponsoredBlackRock is hoarding it. JPMorgan is hoarding it. Do you own it?BlackRock, JPMorgan, Goldman Sachs, and Fidelity are reportedly accumulating a scarce blockchain asset - one t...Awesomely | SponsoredTSM just handed Trump's secretive AI project $100 billionTaiwan Semiconductor just committed another $100 billion to U.S. chip manufacturing - on top of $165 billion a...InvestorPlace | SponsoredThe Starlink of EnergyA portable energy unit - already used by the U.S. Navy for decades - is now drawing serious attention from Big...Monument Traders Alliance | SponsoredElon is about to dominate the biggest arms race in tech historyMicrosoft, Amazon, Alphabet, and Meta have collectively poured nearly $700 billion into AI infrastructure in 2...The Oxford Club | SponsoredIt all happens tonight.Tonight, trader Sean Allison is hosting a live session to walk through his Zero-Dollar Trade Advantage strateg...Trade Thirsty | SponsoredThe options guide that actually starts at the beginningMost options educators jump straight into Greeks, spreads, and implied volatility - losing beginners before th...Base Camp Trading | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Else Nutrn Hldg Please log in to your account or sign up in order to add this asset to your watchlist. Share Else Nutrn With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
